Skip to main content
. 2015 Dec 3;15:1208. doi: 10.1186/s12889-015-2522-7

Table 2.

The 66 clinical biomarkers routinely measured in the Qatar Biobank pilot study

Group Variable
Bone and joint markers Calcium
Phosphorus
Uric acid
Vitamin D
Coagulation tests Activated partial thromboplastin time
Fibrinogen level
International normalized ratio
Prothrombin time
Diabetes related tests C-Peptide
Glucose
Glycated Haemoglobin A1c %
Insulin
Differential white cell count Basophil
Basophil %
Eosinophils
Eosinophils %
Lymphocytes
Lymphocytes %
Monocyte
Monocyte %
Neutrophils
Neutrophils %
White blood cell
Electrolytes and renal function tests Chloride
Serum creatinine
Bicarbonate
Potassium
Sodium
Urea nitrogen
Full blood count Haematocrit
Haemoglobin
Mean corpuscular haemoglobin
Mean corpuscular HGB concentration
Mean corpuscular volume
Mean platelet volume
Platelets
Red blood cell
Sex steroid hormones Estradiol
Sex hormone binding globulin
Testosterone
Inflammation/Autoimmune Rheumatoid factor
C-Reactive protein
Lipid profile Cholesterol
High density lipoprotein
Low density lipoprotein
Triglycerides
Liver function tests Albumin
Alkaline phosphatase
Alanine transaminase
Aspartate transaminase
Gamma glutamyl transferase
Total bilirubin
Total protein
Minerals Iron
Ferritin
Magnesium
Total Iron binding capacity
Muscle markers Creatine kinase
Myoglobin
Thyroid function tests Free triiodothyronine
Free thyroxine
Thyroid stimulating hormone
Vitamins Vitamin B12
Folate serum
Other tests Homocysteine
N-terminal brain-type natriuretic peptide